Condition (MeSH)
Tracheoesophageal Fistula
ClinicalTrials.gov lists 12 trials for Tracheoesophageal Fistula or a narrower condition beneath it. Cook Research Incorporated has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
12 of the 12 trials are tagged with Tracheoesophageal Fistula itself; the rest are tagged with a narrower condition beneath it.
When did Tracheoesophageal Fistula trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Not applicable
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 2 |
| 2018 | 2 |
| 2016 | 1 |
| 2013 | 1 |
| 2011 | 1 |
No forecast is made for this condition: it averages 0.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 12 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Tracheoesophageal Fistula trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Not applicable | 6 |
| Observational | 5 |
How many Tracheoesophageal Fistula trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 4 |
| Terminated | 1 |
| Withdrawn | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Tracheoesophageal Fistula trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Cook Research Incorporated | 1 |
Interventions as named in the registry (1)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| SVF | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Tracheoesophageal Fistula? (54)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Comparison of robotic versus thoracoscopic repair for congenital esophageal atresia: a propensity score matching analysis. | International journal of surgery (London, England) | 2024 | Yes |
| Thoracoscopy versus thoracotomy for esophageal atresia and tracheoesophageal fistula: Outcomes from the Midwest Pediatric Surgery Consortium. | Journal of pediatric surgery | 2023 | Yes |
| Endoscopic treatment in pediatric patients with recurrent and H-type tracheoesophageal fistulas - A systematic review and meta-analysis. | International journal of pediatric otorhinolaryngology | 2023 | Yes |
| Current outcomes of infants with esophageal atresia and tracheoesophageal fistula: A multicenter analysis. | Journal of pediatric surgery | 2022 | Yes |
| Outcome of esophageal atresia in Germany. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus | 2021 | Yes |
Showing 5 of 54 publications.
Prevalence (8)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Isolated tracheoesophageal fistula | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Exact |
| Isolated tracheoesophageal fistula | Point prevalence | 1-9 / 100 000 | Worldwide | Not stated | Exact |
| Isolated tracheoesophageal fistula | Point prevalence | 1-9 / 100 000 | Worldwide | Not stated | Exact |
| Isolated tracheoesophageal fistula | Point prevalence | 1-9 / 100 000 | Australia | Not stated | Exact |
| Isolated tracheoesophageal fistula | Prevalence at birth | 1-9 / 100 000 | Worldwide | Not stated | Exact |
Showing 5 of 8 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Isolated tracheoesophageal fistula | 454750 | Exact | Orphadata Science knowledge files, Product 1 |
| Isolated tracheoesophageal fistula | 454750 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.